EUVIMEDEUVIMED entdecken
Crossref

Anti-Idiotypic Antibodies and “Tumor-Only” Antigens: An Update

Alejandro Lopez-Requena, Oscar R. Burrone

The Open Immunology Journal · 2009

DOI: 10.2174/1874226200902010001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Open Immunology Journal, 2009. Verfasst von Alejandro Lopez-Requena und 1 weiteren Autor:innen. Die Arbeit wurde bisher 7-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The use of anti-idiotypic antibodies for cancer treatment continues to be a major field of investigation.One major challenge for tumor immunotherapy is the identification of antigens associated only or preferably with malignant cells.We summarize here some of the most recent preclinical and clinical advances using two targets that can be considered tumor-specific antigens: N-glycolyl (NeuGc)-gangliosides and the idiotype of B cell lymphomas.Recent developments with tumor-associated protein antigens and the role of anti-idiotypic antibodies in autoimmune diseases are also discussed.

Zitieren

APA

Lopez-Requena, A., & Burrone, O. R. (2009). Anti-Idiotypic Antibodies and “Tumor-Only” Antigens: An Update. The Open Immunology Journal. https://doi.org/10.2174/1874226200902010001

Vancouver

Lopez-Requena A, Burrone OR. Anti-Idiotypic Antibodies and “Tumor-Only” Antigens: An Update. The Open Immunology Journal. 2009. doi:10.2174/1874226200902010001

BibTeX
@article{LopezRequena2009,
  author = {Lopez-Requena, Alejandro and Burrone, Oscar R.},
  title = {Anti-Idiotypic Antibodies and “Tumor-Only” Antigens: An Update},
  journal = {The Open Immunology Journal},
  year = {2009},
  doi = {10.2174/1874226200902010001}
}
Kostenlos starten →